Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Horizon And Arrowhead To Develop RNAi Therapeutic For Gout
Target Is Xanthine Dehydrogenase, Primary Source Of Serum Uric Acid
Jun 22 2021
•
By
Sten Stovall
Gout Pact Will Give Arrowhead $40m upfront • Source: Alamy
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Immunological
More from Therapy Areas